PH14398A - Pharmaceutical compounds,compositions containing same and method of use - Google Patents

Pharmaceutical compounds,compositions containing same and method of use

Info

Publication number
PH14398A
PH14398A PH20569A PH20569A PH14398A PH 14398 A PH14398 A PH 14398A PH 20569 A PH20569 A PH 20569A PH 20569 A PH20569 A PH 20569A PH 14398 A PH14398 A PH 14398A
Authority
PH
Philippines
Prior art keywords
compositions containing
pharmaceutical compounds
containing same
pharmaceutical
compounds
Prior art date
Application number
PH20569A
Other languages
English (en)
Inventor
G Wootton
Original Assignee
Beecham Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB52955/76A external-priority patent/GB1598662A/en
Application filed by Beecham Group Ltd filed Critical Beecham Group Ltd
Publication of PH14398A publication Critical patent/PH14398A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C07D233/76—Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C273/00—Preparation of urea or its derivatives, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C273/18—Preparation of urea or its derivatives, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups of substituted ureas
    • C07C273/1809—Preparation of urea or its derivatives, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups of substituted ureas with formation of the N-C(O)-N moiety
    • C07C273/1818—Preparation of urea or its derivatives, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups of substituted ureas with formation of the N-C(O)-N moiety from -N=C=O and XNR'R"
    • C07C273/1827—X being H
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/86—Oxygen and sulfur atoms, e.g. thiohydantoin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PH20569A 1976-12-18 1977-12-19 Pharmaceutical compounds,compositions containing same and method of use PH14398A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB52955/76A GB1598662A (en) 1976-12-18 1976-12-18 10,12-diazoprostaglandins
GB3036977 1977-07-20

Publications (1)

Publication Number Publication Date
PH14398A true PH14398A (en) 1981-06-25

Family

ID=26260409

Family Applications (1)

Application Number Title Priority Date Filing Date
PH20569A PH14398A (en) 1976-12-18 1977-12-19 Pharmaceutical compounds,compositions containing same and method of use

Country Status (15)

Country Link
JP (1) JPS5382779A (de)
AT (1) AT368498B (de)
AU (1) AU514523B2 (de)
CH (1) CH639076A5 (de)
DE (1) DE2755771A1 (de)
DK (1) DK551777A (de)
ES (1) ES465176A1 (de)
FI (1) FI773812A7 (de)
FR (1) FR2374309A1 (de)
IL (1) IL53559A0 (de)
NL (1) NL7713971A (de)
NO (1) NO774348L (de)
NZ (1) NZ185909A (de)
PH (1) PH14398A (de)
SE (1) SE7714373L (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1602188A (en) * 1977-12-01 1981-11-11 Wellcome Found Hydantoin derivatives
JPS5492962A (en) * 1977-12-01 1979-07-23 Wellcome Found Thiohydantoin compound
DE2963795D1 (en) * 1978-01-23 1982-11-11 Beecham Group Plc Hydantoins and thiohydantoins, method for their preparation and pharmaceutical compositions containing them
EP0004723A1 (de) * 1978-03-30 1979-10-17 Beecham Group Plc Deoxyhydantoine, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
EP0006352A1 (de) * 1978-06-15 1980-01-09 Beecham Group Plc Hydantoine und Thiohydantoine, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
AU4778279A (en) * 1978-06-15 1979-12-20 Beecham Group Limited Prostaglandin analogues
IL57504A0 (en) * 1978-06-15 1979-10-31 Beecham Group Ltd Prostagandin analogues,their preparation and pharmaceutical compositions containing
AU4806979A (en) * 1978-06-15 1979-12-20 Beecham Group Limited 1,2,4 triazole derivatives
EP0019223A1 (de) * 1979-05-09 1980-11-26 The Wellcome Foundation Limited Optisch aktive Hydantoinderivate, ihre Herstellung, sie enthaltende pharmazeutische Formulierungen und Zwischenprodukte

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2323193A1 (de) 1972-05-10 1973-11-22 Du Pont Pyrazolidinone
FR2258376A1 (en) 1974-01-21 1975-08-18 Aries Robert 10-Aza prostaglandins - for treatment of blood pressure and gastro-intestinal disorders and in prepn for confinement
GB1524818A (en) 1974-11-29 1978-09-13 Beecham Group Ltd 12-azaprostaglandins

Also Published As

Publication number Publication date
AU514523B2 (en) 1981-02-12
ATA893777A (de) 1982-02-15
ES465176A1 (es) 1979-01-01
AU3161377A (en) 1979-06-21
SE7714373L (sv) 1978-06-19
NZ185909A (en) 1980-11-14
FR2374309A1 (fr) 1978-07-13
CH639076A5 (en) 1983-10-31
DE2755771A1 (de) 1978-06-29
FR2374309B1 (de) 1980-05-16
FI773812A7 (fi) 1978-06-19
NO774348L (no) 1978-06-20
AT368498B (de) 1982-10-11
IL53559A0 (en) 1978-03-10
JPS5382779A (en) 1978-07-21
NL7713971A (nl) 1978-06-20
DK551777A (da) 1978-06-19

Similar Documents

Publication Publication Date Title
PH16326A (en) New chemical compounds,pharmaceutical compositions containing the same and method of use
PH15877A (en) Novel n-heterocyclyl-4-piperidiamines,pharmaceutical composition containing same and method of use
EG12043A (en) Herbicide,composition containing the compound and method of use
ZA771998B (en) Triazolo-pyrimidines and pharmaceutical compositions containing them
PH18091A (en) Novel spiro-oxazolidindiones,pharmaceutical compositions containing same and method of use thereof
PH15719A (en) Aminoalkylbenzoic derivatives,pharmaceutical composition and method of use
NZ185356A (en) 1-aryloxy-2-hydroxy-3-alkyleneaminopropanes and pharmaceutical compositions containing them
GB1524578A (en) Aminobenzoamide compounds and pharmaceutical compositions containing them
JPS52102432A (en) Pharmaceutical composition containing pyretrinoid
PH14401A (en) Hydroxyaminohydrocarbonphosphonic acid derivatives,compositions containing same and method of use
PH15886A (en) 3-aminopropoxy derivatives,pharmaceutical compositions containing them and their use
PH14356A (en) Derivatives of penicillanic acid,compositions containing same and method of use
PH17959A (en) Penicillanic acid derivatives,pharmaceutical compositions containing the same and method of use thereof
IL51339A0 (en) New beta-lactam containing compounds their preparation and pharmaceutical compositions containing them
GB1544191A (en) Acylaminopiperidines processes for their preparation and pharmaceutical compositions containing them
IL52433A (en) 2-bromo-6-fluoro-n-2-imidazolidinylidene-benzamine and pharmaceutical compositions containing them
PH15375A (en) Sulphide compounds,pharmaceutical composition and method of use
PH14589A (en) Dipepting derivatives and compositions containing same
PH13924A (en) Glavulanic acid derivatives,pharmaceutical compositions containing same and method of preparation thereof
PH14058A (en) 16-s-acyl derivatives of fusidic acid,pharmaceutical compositions containing same and method of treatment thereof
NZ184102A (en) Derivatives of benzenesulphonylurea,and pharmaceutical compositions
IL51572A0 (en) New substituted purines and pharmaceutical compositions containing them
NZ185267A (en) Derivatives of 1-amino-2hydroxy-3-heterocycloxy-propanes, and pharmaceutical compositions containing them
IL53030A (en) Derivatives of 9-chloroprednisolone,processes for their preparation and pharmaceutical compositions containing the same
IL52207A (en) Substituted 2-vinyl-chromones, process for their preparation and pharmaceutical compositions containing them